PTHrP analogue
Abaloparatide
Answer
Abaloparatide is authorised or registered in the US, the EU, the UK, Australia and Switzerland: 5 of the 10 registers read. No trial states a phase. It has 25 registered trials, 7 of them running. Brand names on the FDA label register: Tymlos.
RegulatorTrial register10 regulators' registers, read 2026-09-03 to 2026-10-03 · ClinicalTrials.gov, read 2026-10-03
Not medical, legal or regulatory advice.
25 trials by status
Trial registerClinicalTrials.gov · read 2026-10-03 · 11 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 1 trial carries no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Authorised | EMA, ema | 2026-10-03 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Not on the register | Health Canada, ca-dpd | 2026-09-03 |
| Australia | Registered | TGA, au-artg | 2026-10-03 |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-10-03 |
| Brazil | Not on the register | ANVISA, br-anvisa | 2026-09-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Not on the register | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Abaloparatide changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 25 trials
| NCT03841058 | Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery running, but no longer enrolling · register updated 2026-09-28 |
|---|---|
| NCT07587775 | The Effect of Osteoporotic Medications on Vertebral Bone Quality Score enrolling by invitation only · register updated 2026-07-23 |
| NCT06164795 | Sequential Therapies After Osteoanabolic Treatment currently recruiting participants · register updated 2026-07-22 |
| NCT04467983 | Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone running, but no longer enrolling · register updated 2026-06-08 |
| NCT04167163 | Abaloparatide Before Total Knee Arthroplasty completed · register updated 2026-06-05 |
| NCT07616401 | MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis currently recruiting participants · register updated 2026-06-01 |
| NCT06898060 | To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosi not yet recruiting participants · register updated 2025-03-27 |
| NCT06753864 | A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Ab not yet recruiting participants · register updated 2024-12-31 |
| NCT04760782 | PTH Analog Type II Odontoid Fracture terminated before completion · register updated 2024-09-19 |
| NCT04249232 | Abaloparatide and Pelvic Fracture Healing completed · register updated 2024-06-14 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.